Johns Hopkins: Study - FDA Regulation of Abortion Drug Mifepristone From 2011 to 2023 Shaped by Evidence and Caution
January 13, 2026
January 13, 2026
BALTIMORE, Maryland, Jan. 13 (TNSjou) -- Johns Hopkins University Bloomberg School of Public Health issued the following news release:
* * *
Study: FDA Regulation of Abortion Drug Mifepristone from 2011 to 2023 Shaped by Evidence and Caution
Researchers reviewed hundreds of internal FDA documents obtained under FOIA
*
An analysis of internal Food and Drug Administration documents by researchers at the Johns Hopkins Bloomberg School . . .
* * *
Study: FDA Regulation of Abortion Drug Mifepristone from 2011 to 2023 Shaped by Evidence and Caution
Researchers reviewed hundreds of internal FDA documents obtained under FOIA
*
An analysis of internal Food and Drug Administration documents by researchers at the Johns Hopkins Bloomberg School . . .